These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26338058)

  • 1. Dextrose-mediated aggregation of therapeutic monoclonal antibodies in human plasma: Implication of isoelectric precipitation of complement proteins.
    Luo S; Zhang B
    MAbs; 2015; 7(6):1094-103. PubMed ID: 26338058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the right diluent for intravenous infusion of therapeutic antibodies.
    Luo S; McSweeney KM; Wang T; Bacot SM; Feldman GM; Zhang B
    MAbs; 2020; 12(1):1685814. PubMed ID: 31774346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggregation of biopharmaceuticals in human plasma and human serum: implications for drug research and development.
    Arvinte T; Palais C; Green-Trexler E; Gregory S; Mach H; Narasimhan C; Shameem M
    MAbs; 2013; 5(3):491-500. PubMed ID: 23571158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of an automated method for compounding monoclonal antibody patient doses: case studies of Avastin (bevacizumab), Remicade (infliximab) and Herceptin (trastuzumab).
    Peters BJ; Capelle MA; Arvinte T; van de Garde EM
    MAbs; 2013; 5(1):162-70. PubMed ID: 23255057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of imaged capillary isoelectric focusing and cation exchange chromatography for monitoring dextrose-mediated glycation of monoclonal antibodies in infusion solutions.
    Demirdirek B; Lan W; Qiu D; Ding W; Iyer LK; Bolgar MS; Valente JJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():156-163. PubMed ID: 30594826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyphenation of strong cation exchange chromatography to native mass spectrometry for high throughput online characterization of charge heterogeneity of therapeutic monoclonal antibodies.
    Ma F; Raoufi F; Bailly MA; Fayadat-Dilman L; Tomazela D
    MAbs; 2020; 12(1):1763762. PubMed ID: 32370592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3, C4 and C5: the thioester site.
    Law SK; Dodds AW
    Biochem Soc Trans; 1990 Dec; 18(6):1155-9. PubMed ID: 2088831
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator.
    Whaley K; Ruddy S
    Science; 1976 Sep; 193(4257):1011-3. PubMed ID: 948757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective adsorption of immunoglobulins and glucosylated proteins on phenylboronate-agarose.
    Brena BM; Batista-Viera F; Rydén L; Porath J
    J Chromatogr; 1992 Jun; 604(1):109-15. PubMed ID: 1639919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bulky Polar Additives That Greatly Reduce the Viscosity of Concentrated Solutions of Therapeutic Monoclonal Antibodies.
    Larson AM; Weight AK; Love K; Bonificio A; Wescott CR; Klibanov AM
    J Pharm Sci; 2017 May; 106(5):1211-1217. PubMed ID: 28137697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracking Antibody Distribution with Near-Infrared Fluorescent Dyes: Impact of Dye Structure and Degree of Labeling on Plasma Clearance.
    Cilliers C; Nessler I; Christodolu N; Thurber GM
    Mol Pharm; 2017 May; 14(5):1623-1633. PubMed ID: 28294622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the Degradation Behaviors of a Therapeutic Monoclonal Antibody Associated with pH and Buffer Species.
    Zheng S; Qiu D; Adams M; Li J; Mantri RV; Gandhi R
    AAPS PharmSciTech; 2017 Jan; 18(1):42-48. PubMed ID: 26340951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Amyloid P Component (SAP) Interactome in Human Plasma Containing Physiological Calcium Levels.
    Poulsen ET; Pedersen KW; Marzeda AM; Enghild JJ
    Biochemistry; 2017 Feb; 56(6):896-902. PubMed ID: 28098450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New methods allowing the detection of protein aggregates: a case study on trastuzumab.
    Demeule B; Palais C; Machaidze G; Gurny R; Arvinte T
    MAbs; 2009; 1(2):142-50. PubMed ID: 20061815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LC-MS/MS strategies for therapeutic antibodies and investigation into the quantitative impact of antidrug-antibodies.
    Ewles M; Mannu R; Fox C; Stanta J; Evans G; Goodwin L; Duffy J; Bell L; Estdale S; Firth D
    Bioanalysis; 2016 Dec; 8(24):2565-2579. PubMed ID: 27884074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat-induced fragmentation of human plasma fibronectin.
    Miekka SI
    Biochim Biophys Acta; 1983 Nov; 748(3):374-80. PubMed ID: 6196054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of Light-Accelerated Degradation on the Aggregation of Marketed Therapeutic Monoclonal Antibodies Evaluated by Size-Exclusion Chromatography With Diode Array Detection.
    Hernández-Jiménez J; Salmerón-García A; Cabeza J; Vélez C; Capitán-Vallvey LF; Navas N
    J Pharm Sci; 2016 Apr; 105(4):1405-18. PubMed ID: 26952878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of human and mouse complement C3.
    Ruseva MM; Heurich M
    Methods Mol Biol; 2014; 1100():75-91. PubMed ID: 24218251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EAC4 and EAC14 production without purified Ci.
    Linscott WD
    J Immunol; 1975 Dec; 115(6):1625-30. PubMed ID: 241767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.